EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer.

Amato KR, Wang S, Tan L, Hastings AK, Song W, Lovly CM, Meador CB, Ye F, Lu P, Balko JM, Colvin DC, Cates JM, Pao W, Gray NS, Chen J
Cancer Res. 2016 76 (2): 305-18

PMID: 26744526 · PMCID: PMC4715957 · DOI:10.1158/0008-5472.CAN-15-0717

MeSH Terms (19)

Animals Antineoplastic Combined Chemotherapy Protocols Apoptosis Benzamides Cell Line, Tumor Cell Proliferation Drug Resistance, Neoplasm Drug Synergism ErbB Receptors Erlotinib Hydrochloride Humans Lung Neoplasms Mice Mice, Nude Niacinamide Protein Kinase Inhibitors Receptor, EphA2 Signal Transduction Xenograft Model Antitumor Assays

Connections (3)

This publication is referenced by other Labnodes entities:

Links